Suchergebnisse - "IgA"

PubPharm (297)

1

Clinical significance of urinary inflammatory biomarkers in patients with IgA nephropathy

enthalten in: BMC nephrology | 2024

von Yoon, S. | Kim, J. | Jung, S. | +6

2

Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis

enthalten in: International immunopharmacology | 2024

von Gan, T. | Qu, L. | Qu, S. | +10

3

Conditional power and information fraction calculations at an interim analysis for random coefficient models

enthalten in: Pharmaceutical statistics | 2024

von Lewis, S. | Carroll, K. | DeVries, T. | +1

4

Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy

enthalten in: Renal failure | 2024

von Zhang, Q. | Zhao, Y. | Luo, Y. | +4

5

Prognostic significance of circulating microparticles in IgA nephropathy

enthalten in: International urology and nephrology | 2024

von Bharti, N. | Rai, M. | Singh, S. | +4

6

Identification of inflammatory biomarkers in IgA nephropathy using the NanoString technology : a validation study in Caucasians

enthalten in: Inflammation research : official journal of the European Histamine Research Society ... [et al. | 2024

von Gaumond, L. | Lamarche, C. | Beauchemin, S. | +4

7

Metabolomics study reveals blood biomarkers for early diagnosis of chronic kidney disease and IgA nephropathy : A retrospective cross-sectional study

enthalten in: Clinica chimica acta; international journal of clinical chemistry | 2024

von Fu, X. | Luo, Z. | Yin, H. | +4

8

Identification of inflammatory biomarkers in IgA nephropathy using the NanoString technology: a validation study in Caucasians

enthalten in: Inflammation research | 2024

von Gaumond, L. | Lamarche, C. | Beauchemin, S. | +4

9

Role of metabolomic profile as a potential marker to discriminate membranous nephropathy from IgA nephropathy

enthalten in: International urology and nephrology | 2024

von Qu, Y. | Wang, Y. | Hu, Z. | +5

10

Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy

enthalten in: Kidney international | 2024

von Zhang, H. | Rizk, D. | Perkovic, V. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[30]